- Home
- BLNK vs RENB Comparison
BLNK vs RENB Comparison
Compare BLNK & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- RENB
- Stock Information
- Founded
- BLNK 2009
- RENB 2011
- Country
- BLNK United States
- RENB United States
- Employees
- BLNK N/A
- RENB N/A
- Industry
- BLNK Industrial Specialties
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- RENB Health Care
- Exchange
- BLNK Nasdaq
- RENB Nasdaq
- Market Cap
- BLNK 77.3M
- RENB 62.0M
- IPO Year
- BLNK N/A
- RENB N/A
- Fundamental
- Price
- BLNK $0.93
- RENB $0.34
- Analyst Decision
- BLNK Buy
- RENB
- Analyst Count
- BLNK 8
- RENB 0
- Target Price
- BLNK $2.61
- RENB N/A
- AVG Volume (30 Days)
- BLNK 2.9M
- RENB 7.5M
- Earning Date
- BLNK 08-06-2025
- RENB 05-15-2025
- Dividend Yield
- BLNK N/A
- RENB N/A
- EPS Growth
- BLNK N/A
- RENB N/A
- EPS
- BLNK N/A
- RENB N/A
- Revenue
- BLNK $109,383,000.00
- RENB N/A
- Revenue This Year
- BLNK N/A
- RENB N/A
- Revenue Next Year
- BLNK $31.15
- RENB N/A
- P/E Ratio
- BLNK N/A
- RENB N/A
- Revenue Growth
- BLNK N/A
- RENB N/A
- 52 Week Low
- BLNK $0.63
- RENB $0.27
- 52 Week High
- BLNK $3.75
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- BLNK 59.46
- RENB 49.44
- Support Level
- BLNK $0.84
- RENB $0.32
- Resistance Level
- BLNK $0.92
- RENB $0.40
- Average True Range (ATR)
- BLNK 0.07
- RENB 0.06
- MACD
- BLNK 0.01
- RENB 0.01
- Stochastic Oscillator
- BLNK 60.25
- RENB 39.67
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.